Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel
| Autor: | Amit Huppert, Arnon Afek, Yaniv Lustig, Galia Rahav, Arnona Ziv, Sharon Amit, Eyal Leshem, Yitshak Kreiss, Carmit Rubin, Ilya Novikov, Ram Doolman, Rebecca Kahn, Gili Regev-Yochay, Moriah Bergwerk, Irena Gimpelevich, Carmit Cohen, Marc Lipsitch |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Infectivity
medicine.medical_specialty business.industry Transmission (medicine) Health Policy Incidence (epidemiology) Asymptomatic Herd immunity Vaccination Oncology Internal medicine Internal Medicine medicine Viral shedding medicine.symptom Public aspects of medicine RA1-1270 Prospective cohort study business Research Paper |
| Zdroj: | The Lancet Regional Health. Europe, Vol 7, Iss, Pp 100150-(2021) The Lancet Regional Health. Europe |
| ISSN: | 2666-7762 |
| Popis: | Background: BNT162b2 was shown to be 92% effective in preventing COVID-19. Prioritizing vaccine rollout, and achievement of herd immunity depend on SARS-CoV-2 transmission reduction. The vaccine's effect on infectivity is thus a critical priority. Methods: Among all 9650 HCW of a large tertiary medical center in Israel, we calculated the prevalence of positive SARS-CoV-2 qRT-PCR cases with asymptomatic presentation, tested following known or presumed exposure and the infectious subset (N-gene-Ct-value |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|